IP Verse

Ngm Biopharmaceuticals, Inc. / Merck Sharp & Dohme Corp. competitive analysis

Latest oppositions filed by Ngm Biopharmaceuticals, Inc. / Merck Sharp & Dohme Corp.

Explore patent oppositions filed by Ngm Biopharmaceuticals, Inc. / Merck Sharp & Dohme Corp. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP2550972
Klotho-Beta For Use In Treating Cancer, Liver Disorders, Gallstones, Wasting Syndrome And Obesity-Related DiseasesGENENTECHNov 20, 2018
EP2694092
Method Of Treating Or Ameliorating Metabolic Disorders Using Growth Differentiation Factor 15 (Gdf-15)AMGENOct 4, 2017

Latest PTAB cases involving Ngm Biopharmaceuticals, Inc. / Merck Sharp & Dohme Corp.

Discover the latest PTAB cases involving Ngm Biopharmaceuticals, Inc. / Merck Sharp & Dohme Corp., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ngm Biopharmaceuticals, Inc. / Merck Sharp & Dohme Corp. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NGM BIOPHARMACEUTICALS, INC. / MERCK SHARP & DOHME CORP.1 - - -
GENENTECH - 146 - 66